Many studies have reported that over expression of PD-1 is associated with poor prognosis in several tumors, which including breast, cervical, gastric, esophageal cancers and non-small cell lung cancer (NSCLC) [7–10, 39]. This evidence concerns the gene PDCD1 and esophageal cancer.